FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Caj Haglund

Research Profile

Chemicals & Drugs

Procedures

Concepts & Ideas

Disorders

Co-author Network

Publications

TOP 3
Abdirisak Ahmed Haji Omar; Timo Atula; Caj Haglund; Jaana Hagström; Valtteri Häyry; Risto Kontio; Antti Pihakari; Jarmo Rihtniemi; Tuula Salo; Susanna Virolainen; Timo Sorsa
Epithelial and stromal syndecan-1 and -2 are distinctly expressed in oral- and cutaneous squamous cell carcinomas.
Annukka Heikkilä; I Heiskanen; Johanna Louhimo; Hanna Mäenpää; Päivi Siironen; Caj Haglund; Jaana Hagström; Johanna Arola
Loss of estrogen receptor Beta expression in follicular thyroid carcinoma predicts poor outcome.
Kethe Hermunen; Caj Haglund; Pia Osterlund
CEA fluctuation during a single fluorouracil-based chemotherapy cycle for metastatic colorectal cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Caj Haglund (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Abdirisak Ahmed Haji Omar; Timo Atula; Caj Haglund; Jaana Hagström; Valtteri Häyry; Risto Kontio; Antti Pihakari; Jarmo Rihtniemi; Tuula Salo; Susanna Virolainen; Timo Sorsa
Epithelial and stromal syndecan-1 and -2 are distinctly expressed in oral- and cutaneous squamous cell carcinomas.
Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 2013;42(5):389-95.
2013: Annukka Heikkilä; I Heiskanen; Johanna Louhimo; Hanna Mäenpää; Päivi Siironen; Caj Haglund; Jaana Hagström; Johanna Arola
Loss of estrogen receptor Beta expression in follicular thyroid carcinoma predicts poor outcome.
Thyroid : official journal of the American Thyroid Association 2013;23(4):456-65.
2013: Kethe Hermunen; Caj Haglund; Pia Osterlund
CEA fluctuation during a single fluorouracil-based chemotherapy cycle for metastatic colorectal cancer.
Anticancer research 2013;33(1):253-60.
2012: Maria Kouzmina; Junnu Leikola; Tom Böhling; Caj Haglund; Valtteri Häyry; Virve Koljonen; Jaana Hagström
BMI1 expression identifies subtypes of Merkel cell carcinoma.
Virchows Archiv : an international journal of pathology 2012;461(6):647-53.
2012: Suvi Renkonen; Outi Monni; Caj Haglund; Jaana Hagström; Matti Kankainen; Antti A Mäkitie
Systems-level analysis of clinically different phenotypes of juvenile nasopharyngeal angiofibromas.
The Laryngoscope 2012;122(12):2728-35.
2012: Helka Sahi; Harri Sihto; Erkki Tukiainen; Caj Haglund; Heli Kavola; Virve Koljonen; Tom Böhling
Bcl-2 expression indicates better prognosis of Merkel cell carcinoma regardless of the presence of Merkel cell polyomavirus.
Virchows Archiv : an international journal of pathology 2012;461(5):553-9.
2012: Alexandra Thiel; Catherine Tomasetto; Caj Haglund; Mira Heinonen; Annabrita Hemmes; Tomi P Mäkelä; Kirsi Narko; Marie-Christine Rio; Ari Ristimäki
Inhibition of cyclooxygenase-2 causes regression of gastric adenomas in trefoil factor 1 deficient mice.
International journal of cancer. Journal international du cancer 2012;131(5):1032-41.
2012: Laura K Mäkinen; Antti Mäkitie; Fabricio Passador-Santos; Tuula Salo; Timo Sorsa; Timo Atula; Camilla Böckelman; Caj Haglund; Valtteri Häyry; Harri Keski-Säntti; Ilmo Leivo; Jaana Hagström
Prognostic significance of matrix metalloproteinase-2, -8, -9, and -13 in oral tongue cancer.
Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 2012;41(5):394-9.
2012: Lin Feng; Caj Haglund; Tho Huu Ho; Kristina Hotakainen; Denis Kainov; Susanna Lintula; Arto Orpana; Annukka Paju; Maria Anastasina; Ulf-Håkan Stenman; Jakob Stenman
Technique for strand-specific gene-expression analysis and monitoring of primer-independent cDNA synthesis in reverse transcription.
BioTechniques 2012;52(4):263-70.
2012: Jaana Hagström; Annukka Heikkilä; I Heiskanen; Johanna Louhimo; Hanna Mäenpää; Päivi Siironen; Johanna Arola; Caj Haglund
TLR-4 expression and decrease in chronic inflammation: indicators of aggressive follicular thyroid carcinoma.
Journal of clinical pathology 2012;65(4):333-8.
2012: Camilla Böckelman; Jaana Hagström; Selja Koskensalo; Mikael Lundin; Ari Ristimäki; Caj Haglund
CIP2A overexpression is associated with c-Myc expression in colorectal cancer.
Cancer biology & therapy 2012;13(5):289-95.
2012: Heli Kukko; Arun Pokhrel; Tom Böhling; Caj Haglund; Virve Koljonen; Risto Sankila; Erkki Tukiainen; Eero Pukkala
Merkel cell carcinoma - a population-based epidemiological study in Finland with a clinical series of 181 cases.
European journal of cancer (Oxford, England : 1990) 2012;48(5):737-42.
2012: Selja Koskensalo; Nina Linder; Johanna Louhimo; Mikael Lundin; Timo Sorsa; Jaana Hagström; Caj Haglund
Lack of MMP-9 expression is a marker for poor prognosis in Dukes' B colorectal cancer.
BMC clinical pathology 2012;12():24.
2012: Selja Koskensalo; Johanna Louhimo; Ulf-Håkan Stenman; Jaana Hagström; Caj Haglund
Tumour-associated trypsin inhibitor TATI is a prognostic marker in colorectal cancer.
Oncology 2012;82(4):234-41.
2012: Juho Konsti; Nina Linder; Kirsimari Aaltonen; Carl Blomqvist; Caj Haglund; Mikael Lundin; Heli Nevanlinna; Stig Nordling; Johan Lundin
Effect of image compression and scaling on automated scoring of immunohistochemical stainings and segmentation of tumor epithelium.
Diagnostic pathology 2012;7():29.
2012: Nina Linder; Timo Ahonen; Caj Haglund; Juho Konsti; Mikael Lundin; Stig Nordling; Matti Pietikäinen; Esa Rahtu; Riku Turkki; Johan Lundin
Identification of tumor epithelium and stroma in tissue microarrays using texture analysis.
Diagnostic pathology 2012;7():22.
2012: Juha Jernman; Johanna Louhimo; Matti J Välimäki; Caj Haglund; Johanna Arola
The novel WHO 2010 classification for gastrointestinal neuroendocrine tumours correlates well with the metastatic potential of rectal neuroendocrine tumours.
Neuroendocrinology 2012;95(4):317-24.
2011: M Skog; K Alitalo; L C Andersson; Petri Bono; Heikki Joensuu; N Linder; Johanna Louhimo; Johan Lundin; Mikael Lundin; T V Petrova; Caj Haglund
Expression and prognostic value of transcription factor PROX1 in colorectal cancer.
British journal of cancer 2011;105(9):1346-51.
2011: C Böckelman; Ralf Bützow; Caj Haglund; Annabrita Hemmes; Heini Lassus; Arto Leminen; Jukka Westermarck; Ari Ristimäki
Prognostic role of CIP2A expression in serous ovarian cancer.
British journal of cancer 2011;105(7):989-95.
2011: Mira Heinonen; Annabrita Hemmes; Marko Laakso; Marjut Leidenius; Kotb Abdelmohsen; Myriam Gorospe; Caj Haglund; Sampsa Hautaniemi; Päivi Heikkilä; Kaisa Salmenkivi; Tuula Salo; Suvi-Tuuli Vilén; Ari Ristimäki
Role of RNA binding protein HuR in ductal carcinoma in situ of the breast.
The Journal of pathology 2011;224(4):529-39.
2011: Kristiina Joensuu; Marjut Leidenius; Hannu Sariola; Leif C Andersson; Caj Haglund; Jaana Hagström; Päivi Heikkilä
Bmi-1, c-myc, and Snail expression in primary breast cancers and their metastases--elevated Bmi-1 expression in late breast cancer relapses.
Virchows Archiv : an international journal of pathology 2011;459(1):31-9.
2011: C Böckelman; Timo Atula; J Hagström; V Häyry; Harri Keski-Säntti; Johan Lundin; L K Mäkinen; Ari Ristimäki; Caj Haglund
High CIP2A immunoreactivity is an independent prognostic indicator in early-stage tongue cancer.
British journal of cancer 2011;104(12):1890-5.
2011: Jaana Hagström; Karri Mesimäki; Satu Apajalahti; Caj Haglund; Mikko Rönty; Maarit Sarlomo-Rikala
A rare case of oral epithelioid sarcoma of the gingiva.
Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 2011;111(4):e25-8.
2011: Selja Koskensalo; Johanna Louhimo; Stig Nordling; Jaana Hagström; Caj Haglund
MMP-7 as a prognostic marker in colorectal cancer.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2011;32(2):259-64.
2011: Tuija M Ylä-Kotola; Susanna C Kauhanen; Ilmo Leivo; Caj Haglund; Erkki Tukiainen
Vascular endothelial growth factor and its receptors are expressed in human nerve grafts.
Journal of reconstructive microsurgery 2011;27(3):173-8.
2011: Suvi Renkonen; Valtteri Häyry; Päivi Heikkilä; Ilmo Leivo; Caj Haglund; Antti A Mäkitie; Jaana Hagström
Stem cell-related proteins C-KIT, C-MYC and BMI-1 in juvenile nasopharyngeal angiofibroma--do they have a role?
Virchows Archiv : an international journal of pathology 2011;458(2):189-95.
2011: Michael J Duffy; Leo G M van Rossum; Sietze T van Turenhout; Outi Malminiemi; Catherine Sturgeon; Rolf Lamerz; Andrea Nicolini; Caj Haglund; Lubos Holubec; Callum G Fraser; Stephen P Halloran
Use of faecal markers in screening for colorectal neoplasia: a European group on tumor markers position paper.
International journal of cancer. Journal international du cancer 2011;128(1):3-11.
2010: Annukka Heikkilä; Päivi Siironen; Jaana Hagström; Ilkka Heiskanen; Risto Sankila; Johanna Louhimo; Caj Haglund; Johanna Arola
Follicular thyroid neoplasm: clinicopathologic features suggesting malignancy.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2010;118(11):846-54.
2010: Selja Koskensalo; Johanna Mrena; Jan-Patrik Wiksten; Stig Nordling; Arto Kokkola; Jaana Hagström; Caj Haglund
MMP-7 overexpression is an independent prognostic marker in gastric cancer.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2010;31(3):149-55.
2010: V Häyry; L K Mäkinen; Timo Atula; H Sariola; Antti A Mäkitie; Ilmo Leivo; Harri Keski-Säntti; Johan Lundin; Caj Haglund; J Hagström
Bmi-1 expression predicts prognosis in squamous cell carcinoma of the tongue.
British journal of cancer 2010;102(5):892-7.
2010: Päivi Siironen; J Hagström; H O Mäenpää; Johanna Louhimo; A Heikkilä; I Heiskanen; J Arola; Caj Haglund
Anaplastic and poorly differentiated thyroid carcinoma: therapeutic strategies and treatment outcome of 52 consecutive patients.
Oncology 2010;79(5-6):400-8.
2010: Johanna Mrena; Jan-Patrik Wiksten; Arto Kokkola; Stig Nordling; Ari Ristimäki; Caj Haglund
COX-2 is associated with proliferation and apoptosis markers and serves as an independent prognostic factor in gastric cancer.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2010;31(1):1-7.
2009: V Häyry; Kaisa Salmenkivi; Johanna Arola; Päivi Heikkilä; Caj Haglund; Hannu Sariola
High frequency of SNAIL-expressing cells confirms and predicts metastatic potential of phaeochromocytoma.
Endocrine-related cancer 2009;16(4):1211-8.
2009: Tero Satomaa; Annamari Heiskanen; Iréne Leonardsson; Jonas Angström; Anne Olonen; Maria Blomqvist; Noora Salovuori; Caj Haglund; Susann Teneberg; Jari Natunen; Olli Carpén; Juhani Saarinen
Analysis of the human cancer glycome identifies a novel group of tumor-associated N-acetylglucosamine glycan antigens.
Cancer research 2009;69(14):5811-9.
2009: Alexandra Thiel; Aparna Ganesan; Johanna Mrena; Siina Junnila; Antti Nykänen; Annabrita Hemmes; Hsin-Hsiung Tai; Outi Monni; Arto Kokkola; Caj Haglund; Tatiana V Petrova; Ari Ristimäki
15-hydroxyprostaglandin dehydrogenase is down-regulated in gastric cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(14):4572-80.
2009: Anchit Khanna; Camilla Böckelman; Annabrita Hemmes; Melissa R Junttila; Jan-Patrik Wiksten; Mikael Lundin; Siina Junnila; Daniel J Murphy; Gerard I Evan; Caj Haglund; Jukka Westermarck; Ari Ristimäki
MYC-dependent regulation and prognostic role of CIP2A in gastric cancer.
Journal of the National Cancer Institute 2009;101(11):793-805.
2009: Nina Linder; Eeva Martelin; Mikael Lundin; Johanna Louhimo; Stig Nordling; Caj Haglund; Johan Lundin
Xanthine oxidoreductase - clinical significance in colorectal cancer and in vitro expression of the protein in human colon cancer cells.
European journal of cancer (Oxford, England : 1990) 2009;45(4):648-55.
2009: Kristina Hotakainen; Pirjo Tanner; Henrik Alfthan; Caj Haglund; Ulf-Hakan Stenman
Comparison of three immunoassays for CA 19-9.
Clinica chimica acta; international journal of clinical chemistry 2009;400(1-2):123-7.
2009: Leena Kylänpää; Jaana Hagström; Anna Lepistö; Tiina Linjama; Päivi Kärkkäinen; Tuula Kiviluoto; Caj Haglund
Syndecan-1 and tenascin expression in cystic tumors of the pancreas.
JOP : Journal of the pancreas 2009;10(4):378-82.
2008: Catharine M Sturgeon; Michael J Duffy; Ulf-Hakan Stenman; Hans Lilja; Nils Brünner; Daniel W Chan; Richard Babaian; Robert C Bast; Barry Dowell; Francisco J Esteva; Caj Haglund; Nadia Harbeck; Daniel F Hayes; Mads Holten-Andersen; George G Klee; Rolf Lamerz; Leendert H Looijenga; Rafael Molina; Hans Jørgen Nielsen; Harry Rittenhouse; Axel Semjonow; Ie-Ming Shih; Paul Sibley; György Sölétormos; Carsten Stephan; Lori J Sokoll; Barry R Hoffman; Eleftherios P Diamandis
National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers.
Clinical chemistry 2008;54(12):e11-79.
2008: Joakim Janér; Sture Andersson; Caj Haglund; Riitta Karikoski; Patrik Lassus
Placental growth factor and vascular endothelial growth factor receptor-2 in human lung development.
Pediatrics 2008;122(2):340-6.
2008: Tatiana V Petrova; Antti Nykänen; Camilla Norrmén; Konstantin I Ivanov; Leif C Andersson; Caj Haglund; Pauli Puolakkainen; Frank Wempe; Harald von Melchner; Gérard Gradwohl; Sakari Vanharanta; Lauri A Aaltonen; Juha Saharinen; Massimiliano Gentile; Alan Clarke; Jussi Taipale; Guillermo Oliver; Kari Alitalo
Transcription factor PROX1 induces colon cancer progression by promoting the transition from benign to highly dysplastic phenotype.
Cancer cell 2008;13(5):407-19.
2008: Lodewijk A A Brosens; Josbert J Keller; Leena Pohjola; Caj Haglund; Folkert H Morsink; Christine A Iacobuzio-Donahue; Michael Goggins; Francis M Giardiello; Ari Ristimäki; G Johan A Offerhaus
Increased expression of cytoplasmic HuR in familial adenomatous polyposis.
Cancer biology & therapy 2008;7(3):424-7.
2008: Virve Koljonen; Tom Böhling; Caj Haglund; Ari Ristimäki
Expression of HuR in Merkel cell carcinoma and in normal skin.
Journal of cutaneous pathology 2008;35(1):10-4.
2007: Mira Heinonen; Rainer Fagerholm; Kirsimari Aaltonen; Outi Kilpivaara; Kristiina Aittomäki; Carl Blomqvist; Päivi Heikkilä; Caj Haglund; Heli Nevanlinna; Ari Ristimäki
Prognostic role of HuR in hereditary breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(23):6959-63.
2007: Johanna Laukkarinen; Gediminas Kiudelis; Marko Lempinen; Sari Räty; Hanna Pelli; Juhani Sand; Esko Kemppainen; Caj Haglund; Isto Nordback
Increased prevalence of subclinical hypothyroidism in common bile duct stone patients.
The Journal of clinical endocrinology and metabolism 2007;92(11):4260-4.
2007: Heli Kukko; Virve Koljonen; Patrik Lassus; Erkki Tukiainen; Caj Haglund; Tom Böhling
Expression of vascular endothelial growth factor receptor-2 in Merkel cell carcinoma.
Anticancer research 2007;27(4C):2587-9.
2007: Heli Kukko; Virve Koljonen; Patrik Lassus; Erkki Tukiainen; Caj Haglund; Tom Böhling
Expression of endostatin in merkel cell carcinoma.
Anticancer research 2007;27(4C):2583-6.
2007: Mikael Lundin; Stig Nordling; Johan Lundin; Caj Haglund
Tenascin-C expression and its prognostic significance in colorectal cancer.
Oncology 2007;72(5-6):403-9.
2007: Joakim Janér; Sture Andersson; Caj Haglund; Patrik Lassus
Pulmonary endostatin perinatally and in lung injury of the newborn infant.
Pediatrics 2007;119(1):e241-6.
2007: Mikael Railo; Johan Lundin; Caj Haglund; Karl von Smitten; Stig Nordling
Ki-67, p53, ER receptors, ploidy and S phase as long-term prognostic factors in T1 node-negative breast cancer.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2007;28(1):45-51.
2006: Virve Koljonen; Erkki Tukiainen; Caj Haglund; Tom Böhling
Proliferative activity detected by Ki67 correlates with poor outcome in Merkel cell carcinoma.
Histopathology 2006;49(5):551-3.
2006: Jakob Stenman; Annukka Paju; Oso Rissanen; Tuomas Tenkanen; Caj Haglund; Jari V Räsänen; Jarmo Salo; Ulf-Hakan Stenman; Arto Orpana
Targeted gene-expression analysis by genome-controlled reverse transcription-PCR.
Clinical chemistry 2006;52(11):1988-96.
2006: Johanna Mrena; Jan-Patrik Wiksten; Arto Kokkola; Stig Nordling; Caj Haglund; Ari Ristimäki
Prognostic significance of cyclin A in gastric cancer.
International journal of cancer. Journal international du cancer 2006;119(8):1897-901.
2006: Katariina Cederqvist; Joakim Janer; Taina Tervahartiala; Timo Sorsa; Caj Haglund; Kaisa Salmenkivi; Ulf-Hakan Stenman; Sture Andersson
Up-regulation of trypsin and mesenchymal MMP-8 during development of hyperoxic lung injury in the rat.
Pediatric research 2006;60(4):395-400.
2006: Nina Linder; Caj Haglund; Mikael Lundin; Stig Nordling; Ari Ristimäki; Arto Kokkola; Johanna Mrena; Jan-Patrik Wiksten; Johan Lundin
Decreased xanthine oxidoreductase is a predictor of poor prognosis in early-stage gastric cancer.
Journal of clinical pathology 2006;59(9):965-71.
2006: Timo Atula; Johan Hedström; Ari Ristimäki; Patrik Finne; Ilmo Leivo; Mari Markkanen-Leppänen; Caj Haglund
Cyclooxygenase-2 expression in squamous cell carcinoma of the oral cavity and pharynx: association to p53 and clinical outcome.
Oncology reports 2006;16(3):485-90.
2006: Joakim Janér; Patrik Lassus; Caj Haglund; Karri Paavonen; Kari Alitalo; Sture Andersson
Pulmonary vascular endothelial growth factor-C in development and lung injury in preterm infants.
American journal of respiratory and critical care medicine 2006;174(3):326-30.
2006: Sebsebe Lemeta; Kaisa Salmenkivi; Lea Pylkkänen; Markku Sainio; Sirkku Saarikoski; Johanna Arola; Päivi Heikkilä; Caj Haglund; Kirsti Husgafvel-Pursiainen; Tom Böhling
Frequent loss of heterozygosity at 6q in pheochromocytoma.
Human pathology 2006;37(6):749-54.
2006: Johanna Mrena; Jan-Patrik Wiksten; Stig Nordling; Arto Kokkola; Ari Ristimäki; Caj Haglund
MMP-2 but not MMP-9 associated with COX-2 and survival in gastric cancer.
Journal of clinical pathology 2006;59(6):618-23.
2006: Päivi Siironen; Ari Ristimäki; Kirsi Narko; Stig Nordling; Johanna Louhimo; Sture Andersson; Reijo Haapiainen; Caj Haglund
VEGF-C and COX-2 expression in papillary thyroid cancer.
Endocrine-related cancer 2006;13(2):465-73.
2006: Virve Koljonen; Erkki Tukiainen; Caj Haglund; Tom Böhling
Cell cycle control by p21, p27 and p53 in Merkel cell carcinoma.
Anticancer research 2006;26(3B):2209-12.
2006: Katariina Cederqvist; Vappu Sirén; Jari Petäjä; Antti Vaheri; Caj Haglund; Sture Andersson
High concentrations of plasminogen activator inhibitor-1 in lungs of preterm infants with respiratory distress syndrome.
Pediatrics 2006;117(4):1226-34.
2006: Anne Juuti; Johanna Louhimo; Stig Nordling; Ari Ristimäki; Caj Haglund
Cyclooxygenase-2 expression correlates with poor prognosis in pancreatic cancer.
Journal of clinical pathology 2006;59(4):382-6.
2006: Alexandra Thiel; Mira Heinonen; Johanna Rintahaka; Tuija Hallikainen; Annabrita Hemmes; Dan A. Dixon; Caj Haglund; Ari Ristimäki
Expression of cyclooxygenase-2 is regulated by glycogen synthase kinase-3beta in gastric cancer cells.
The Journal of biological chemistry 2006;281(8):4564-9.
2006: Anne Juuti; Johan Lundin; Stig Nordling; Johanna Louhimo; Caj Haglund
Epithelial MMP-2 expression correlates with worse prognosis in pancreatic cancer.
Oncology 2006;71(1-2):61-8.
2006: Jakob Stenman; Jari V Räsänen; T Tenkanen; Caj Haglund; J Salo; Arto Orpana; Annukka Paju
Genome-controlled reverse transcriptase-polymerase chain reaction for targeted gene-expression analysis.
Scandinavian journal of clinical and laboratory investigation 2006;66(7):597-606.
2006: Virve Koljonen; Tom Böhling; Erkki Tukiainen; Caj Haglund; Tiina Jahkola
Tenascin-C expression in Merkel cell carcinoma lymph node metastasis.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2006;114(1):39-42.
2006: Patrik Lassus; J Janer; Caj Haglund; R Karikoski; Leif C Andersson; S Andersson
Consistent expression of HGF and c-met in the perinatal lung.
Biology of the neonate 2006;90(1):28-33.
2006: Kristina Hotakainen; Anders Bjartell; Anna Sankila; R Järvinen; Annukka Paju; Erkki Rintala; Caj Haglund; Ulf-Hakan Stenman
Differential expression of trypsinogen and tumor-associated trypsin inhibitor (TATI) in bladder cancer.
International journal of oncology 2006;28(1):95-101.
2005: Johanna Mrena; Jan-Patrik Wiksten; Alexandra Thiel; Arto Kokkola; Leena Pohjola; Johan Lundin; Stig Nordling; Ari Ristimäki; Caj Haglund
Cyclooxygenase-2 is an independent prognostic factor in gastric cancer and its expression is regulated by the messenger RNA stability factor HuR.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(20):7362-8.
2005: Anna Sivula; Christianne J Buskens; Bastiaan P van Rees; Caj Haglund; G Johan A Offerhaus; J J B van Lanschot; Ari Ristimäki
Prognostic role of cyclooxygenase-2 in neoadjuvant-treated patients with squamous cell carcinoma of the esophagus.
International journal of cancer. Journal international du cancer 2005;116(6):903-8.
2005: Tiina-Liisa Erkinheimo; Anna Sivula; Heini Lassus; Mira Heinonen; Henry Furneaux; Caj Haglund; Ralf Butzow; Ari Ristimäki
Cytoplasmic HuR expression correlates with epithelial cancer cell but not with stromal cell cyclooxygenase-2 expression in mucinous ovarian carcinoma.
Gynecologic oncology 2005;99(1):14-9.
2005: Patrik Lassus; Ari Ristimäki; Riikka Huuhtanen; Erkki Tukiainen; Sirpa Asko-Seljavaara; Leif C Andersson; Markku Miettinen; Carl Blomqvist; Caj Haglund; Tom Böhling
Cyclooxygenase-2 expression in human soft-tissue sarcomas is related to epithelial differentation.
Anticancer research 2005;25(4):2669-74.
2005: Katariina Cederqvist; Caj Haglund; Päivi Heikkilä; Morley D Hollenberg; Riitta Karikoski; Sture Andersson
High expression of pulmonary proteinase-activated receptor 2 in acute and chronic lung injury in preterm infants.
Pediatric research 2005;57(6):831-6.
2005: Jouni Lauronen; Mikko P Pakarinen; Jorma Halttunen; Pekka Kuusanmäki; Caj Haglund; Timo Paavonen
Mucosal expression of p21, p27, p53, Bcl-2, and bax after small bowel resection and autotransplantation in pigs.
Pediatric surgery international 2005;21(5):351-5.
2005: Jan-Patrik Wiksten; Johan Lundin; Stig Nordling; Arto Kokkola; Ulf-Hakan Stenman; Caj Haglund
High tissue expression of tumour-associated trypsin inhibitor (TATI) associates with a more favourable prognosis in gastric cancer.
Histopathology 2005;46(4):380-8.
2005: Mira Heinonen; Petri Bono; Kirsi Narko; Sung-Hee Chang; Johan Lundin; Heikki Joensuu; Henry Furneaux; timothy hla; Caj Haglund; Ari Ristimäki
Cytoplasmic HuR expression is a prognostic factor in invasive ductal breast carcinoma.
Cancer research 2005;65(6):2157-61.
2005: Päivi Siironen; Johanna Louhimo; Stig Nordling; Ari Ristimäki; Hanna Mäenpää; Reijo Haapiainen; Caj Haglund
Prognostic factors in papillary thyroid cancer: an evaluation of 601 consecutive patients.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2005;26(2):57-64.
2005: Virve Koljonen; Caj Haglund; Erkki Tukiainen; Tom Böhling
Neuroendocrine differentiation in primary Merkel cell carcinoma--possible prognostic significance.
Anticancer research 2005;25(2A):853-8.
2005: Virve Koljonen; Tiina Jahkola; Erkki Tukiainen; G Granroth; Caj Haglund; Tom Böhling
Tenascin-C in primary Merkel cell carcinoma.
Journal of clinical pathology 2005;58(3):297-300.
2005: Monika Carpelan-Holmström; Stig Nordling; E Pukkala; R Sankila; J Lüttges; G Klöppel; Caj Haglund
Does anyone survive pancreatic ductal adenocarcinoma? A nationwide study re-evaluating the data of the Finnish Cancer Registry.
Gut 2005;54(3):385-7.
2005: Arto Kokkola; Johanna Louhimo; Pauli Puolakkainen; Henrik Alfthan; Caj Haglund; Hilpi Rautelin
Helicobacter pylori infection and low serum pepsinogen I level as risk factors for gastric carcinoma.
World journal of gastroenterology : WJG 2005;11(7):1032-6.
2005: Anna Sivula; Anne Talvensaari-Mattila; Johan Lundin; Heikki Joensuu; Caj Haglund; Ari Ristimäki; Taina Turpeenniemi-Hujanen
Association of cyclooxygenase-2 and matrix metalloproteinase-2 expression in human breast cancer.
Breast cancer research and treatment 2005;89(3):215-20.
2005: Mikael Lundin; Stig Nordling; Johan Lundin; Jorma Isola; Jan-Patrik Wiksten; Caj Haglund
Epithelial syndecan-1 expression is associated with stage and grade in colorectal cancer.
Oncology 2005;68(4-6):306-13.
2005: Anne Juuti; Stig Nordling; Johan Lundin; Johanna Louhimo; Caj Haglund
Syndecan-1 expression--a novel prognostic marker in pancreatic cancer.
Oncology 2005;68(2-3):97-106.
2005: Päivi Siironen; Stig Nordling; Johanna Louhimo; Reijo Haapiainen; Caj Haglund
Immunohistochemical expression of Bcl-2, Ki-67, and p21 in patients with papillary thyroid cancer.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2005;26(1):50-6.
2005: Virve Koljonen; Patrik Lassus; Erkki Tukiainen; Ari Ristimäki; Caj Haglund; Tom Böhling
Cyclooxygenase-2 expression in primary Merkel cell carcinoma.
Journal of cutaneous pathology 2005;32(1):55-8.
2004: Anne Juuti; Stig Nordling; Johanna Louhimo; Johan Lundin; Caj Haglund
Tenascin C expression is upregulated in pancreatic cancer and correlates with differentiation.
Journal of clinical pathology 2004;57(11):1151-5.
2004: Johanna Louhimo; Arto Kokkola; Henrik Alfthan; Ulf-Hakan Stenman; Caj Haglund
Preoperative hCGbeta and CA 72-4 are prognostic factors in gastric cancer.
International journal of cancer. Journal international du cancer 2004;111(6):929-33.
2004: Monika Carpelan-Holmström; Johanna Louhimo; Ulf-Hakan Stenman; Henrik Alfthan; Heikki Järvinen; Caj Haglund
CEA, CA 242, CA 19-9, CA 72-4 and hCGbeta in the diagnosis of recurrent colorectal cancer.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2004;25(5-6):228-34.
2004: Kaisa Salmenkivi; Päivi Heikkilä; Caj Haglund; Johanna Arola
Malignancy in pheochromocytomas.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2004;112(9):551-9.
2004: Annukka Paju; Juhani Vartiainen; Caj Haglund; Outi Itkonen; Kristina von Boguslawski; Arto Leminen; Torsten Wahlström; Ulf-Hakan Stenman
Expression of trypsinogen-1, trypsinogen-2, and tumor-associated trypsin inhibitor in ovarian cancer: prognostic study on tissue and serum.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(14):4761-8.
2004: Sari Räty; Juhani Sand; Henrik Alfthan; Caj Haglund; Isto Nordback
Cyst fluid tumor-associated trypsin inhibitor may be helpful in the differentiation of cystic pancreatic lesions.
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 2004;8(5):569-74.
2004: Päivi Siironen; Ari Ristimäki; Stig Nordling; Johanna Louhimo; Reijo Haapiainen; Caj Haglund
Expression of COX-2 is increased with age in papillary thyroid cancer.
Histopathology 2004;44(5):490-7.
2004: Tiina-Liisa Erkinheimo; Heini Lassus; Patrik Finne; Bastiaan P van Rees; Arto Leminen; Olavi Ylikorkala; Caj Haglund; Ralf Butzow; Ari Ristimäki
Elevated cyclooxygenase-2 expression is associated with altered expression of p53 and SMAD4, amplification of HER-2/neu, and poor outcome in serous ovarian carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(2):538-45.
2004: Kjell Oberg; Lone Astrup; Barbro Eriksson; Sture Falkmer; Ursula G Falkmer; Jens Gustafsen; Caj Haglund; Ulrich Knigge; Morten Vatn; Matti Välimäki
Guidelines for the management of gastroenteropancreatic neuroendocrine tumours (including bronchopulmonary and thymic neoplasms). Part II-specific NE tumour types.
Acta oncologica (Stockholm, Sweden) 2004;43(7):626-36.
2004: Kjell Oberg; Lone Astrup; Barbro Eriksson; Sture Falkmer; Ursula G Falkmer; Jens Gustafsen; Caj Haglund; Ulrich Knigge; Morten Vatn; Matti Välimäki
Guidelines for the management of gastroenteropancreatic neuroendocrine tumours (including bronchopulmonary and thymic neoplasms). Part I-general overview.
Acta oncologica (Stockholm, Sweden) 2004;43(7):617-25.
2004: Marja Leivonen; Johan Lundin; Stig Nordling; Kristina von Boguslawski; Caj Haglund
Prognostic value of syndecan-1 expression in breast cancer.
Oncology 2004;67(1):11-8.
2004: Monika Carpelan-Holmström; Johanna Louhimo; Ulf-Hakan Stenman; Henrik Alfthan; Heikki Järvinen; Caj Haglund
Estimating the probability of cancer with several tumor markers in patients with colorectal disease.
Oncology 2004;66(4):296-302.
2004: Johanna Louhimo; Henrik Alfthan; Ulf-Hakan Stenman; Caj Haglund
Serum HCG beta and CA 72-4 are stronger prognostic factors than CEA, CA 19-9 and CA 242 in pancreatic cancer.
Oncology 2004;66(2):126-31.
2004: Virve Koljonen; Erkki Tukiainen; Caj Haglund; Tom Böhling
Expression of cyclin A in Merkel cell carcinoma.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2004;112(1):39-44.
2003: Christianne J Buskens; Anna Sivula; Bastiaan P van Rees; Caj Haglund; G Johan A Offerhaus; J J B van Lanschot; Ari Ristimäki
Comparison of cyclooxygenase 2 expression in adenocarcinomas of the gastric cardia and distal oesophagus.
Gut 2003;52(12):1678-83.
2003: Tiina-Liisa Erkinheimo; Heini Lassus; Anna Sivula; Sibani Sengupta; Henry Furneaux; timothy hla; Caj Haglund; Ralf Butzow; Ari Ristimäki
Cytoplasmic HuR expression correlates with poor outcome and with cyclooxygenase 2 expression in serous ovarian carcinoma.
Cancer research 2003;63(22):7591-4.
2003: Kirsi Saukkonen; Johanna Rintahaka; Anna Sivula; Christianne J Buskens; Bastiaan P van Rees; Marie-Christine Rio; Caj Haglund; J J B van Lanschot; G Johan A Offerhaus; Ari Ristimaki
Cyclooxygenase-2 and gastric carcinogenesis.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2003;111(10):915-25.
2003: Petri E Voutilainen; Päivi Siironen; Kaarle Franssila; Anna Sivula; Reijo Haapiainen; Caj Haglund
AMES, MACIS and TNM prognostic classifications in papillary thyroid carcinoma.
Anticancer research 2003;23(5b):4283-8.
2003: Katariina Cederqvist; Caj Haglund; Päivi Heikkilä; Timo Sorsa; Taina Tervahartiala; Ulf-Hakan Stenman; Sture Andersson
Pulmonary trypsin-2 in the development of bronchopulmonary dysplasia in preterm infants.
Pediatrics 2003;112(3 Pt 1):570-7.
2003: Kaisa Salmenkivi; Päivi Heikkilä; Caj Haglund; Johanna Louhimo; Johanna Arola
Lack of histologically suspicious features, proliferative activity, and p53 expression suggests benign diagnosis in phaeochromocytomas.
Histopathology 2003;43(1):62-71.
2003: Timo Atula; Johan Hedström; Patrik Finne; Ilmo Leivo; Mari Markkanen-Leppänen; Caj Haglund
Tenascin-C expression and its prognostic significance in oral and pharyngeal squamous cell carcinoma.
Anticancer research 2003;23(3C):3051-6.
2003: Kristina Hotakainen; Börje Ljungberg; Caj Haglund; Stig Nordling; Annukka Paju; Ulf-Hakan Stenman
Expression of the free beta-subunit of human chorionic gonadotropin in renal cell carcinoma: prognostic study on tissue and serum.
International journal of cancer. Journal international du cancer 2003;104(5):631-5.
2003: Kaisa Salmenkivi; Päivi Heikkilä; Jianqi Liu; Caj Haglund; Johanna Arola
VEGF in 105 pheochromocytomas: enhanced expression correlates with malignant outcome.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2003;111(4):458-64.
2003: Anne Juuti; Stig Nordling; Johanna Louhimo; Johan Lundin; Kristina von Boguslawski; Caj Haglund
Loss of p27 expression is associated with poor prognosis in stage I-II pancreatic cancer.
Oncology 2003;65(4):371-7.
2003: Jan-Patrik Wiksten; Johan Lundin; Stig Nordling; Mikael Lundin; Arto Kokkola; Kristina von Boguslawski; Caj Haglund
Tenascin-C expression correlates with prognosis in gastric cancer.
Oncology 2003;64(3):245-50.
2002: Johanna Louhimo; Monika Carpelan-Holmström; Henrik Alfthan; Ulf-Hakan Stenman; Heikki J Järvinen; Caj Haglund
Serum HCG beta, CA 72-4 and CEA are independent prognostic factors in colorectal cancer.
International journal of cancer. Journal international du cancer 2002;101(6):545-8.
2002: Monika Carpelan-Holmström; Johanna Louhimo; Ulf-Hakan Stenman; Henrik Alfthan; Caj Haglund
CEA, CA 19-9 and CA 72-4 improve the diagnostic accuracy in gastrointestinal cancers.
Anticancer research 2002;22(4):2311-6.
2002: Kristina Hotakainen; Caj Haglund; Annukka Paju; Stig Nordling; Henrik Alfthan; Erkki Rintala; Ulf-Hakan Stenman
Chorionic gonadotropin beta-subunit and core fragment in bladder cancer: mRNA and protein expression in urine, serum and tissue.
European urology 2002;41(6):677-85.
2002: Christianne J Buskens; Bastiaan P van Rees; Anna Sivula; Johannes B Reitsma; Caj Haglund; Piter J Bosma; G Johan A Offerhaus; J J B van Lanschot; Ari Ristimäki
Prognostic significance of elevated cyclooxygenase 2 expression in patients with adenocarcinoma of the esophagus.
Gastroenterology 2002;122(7):1800-7.
2002: Johanna Louhimo; Patrik Finne; Henrik Alfthan; Ulf-Hakan Stenman; Caj Haglund
Combination of HCGbeta, CA 19-9 and CEA with logistic regression improves accuracy in gastrointestinal malignancies.
Anticancer research 2002;22(3):1759-64.
2002: Samuli Hemmer; Veli-Matti Wasenius; Caj Haglund; Ying Zhu; Sakari Knuutila; Kaarle Franssila; Heikki Joensuu
Alterations in the suppressor gene PPP2R1B in parathyroid hyperplasias and adenomas.
Cancer genetics and cytogenetics 2002;134(1):13-7.
2002: Ari Ristimäki; Anna Sivula; Johan Lundin; Mikael Lundin; Tiina Salminen; Caj Haglund; Heikki Joensuu; Jorma Isola
Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer.
Cancer research 2002;62(3):632-5.
2002: Jan-Patrik Wiksten; Johan Lundin; Stig Nordling; Arto Kokkola; Kristina von Boguslawski; Caj Haglund
The prognostic value of p27 in gastric cancer.
Oncology 2002;63(2):180-4.
2001: Kaisa Salmenkivi; Caj Haglund; A Ristimäki; Johanna Arola; Päivi Heikkilä
Increased expression of cyclooxygenase-2 in malignant pheochromocytomas.
The Journal of clinical endocrinology and metabolism 2001;86(11):5615-9.
2001: Kaisa Salmenkivi; Caj Haglund; Johanna Arola; Päivi Heikkilä
Increased expression of tenascin in pheochromocytomas correlates with malignancy.
The American journal of surgical pathology 2001;25(11):1419-23.
2001: Petri E Voutilainen; M M Multanen; Ari Leppäniemi; Caj Haglund; Reijo Haapiainen; Kaarle Franssila
Prognosis after lymph node recurrence in papillary thyroid carcinoma depends on age.
Thyroid : official journal of the American Thyroid Association 2001;11(10):953-7.
2001: Annukka Paju; Timo Sorsa; Taina Tervahartiala; Erkki Koivunen; Caj Haglund; Arto Leminen; Torsten Wahlström; Tuula Salo; Ulf-Hakan Stenman
The levels of trypsinogen isoenzymes in ovarian tumour cyst fluids are associated with promatrix metalloproteinase-9 but not promatrix metalloproteinase-2 activation.
British journal of cancer 2001;84(10):1363-71.
2001: Marja Leivonen; Stig Nordling; Johan Lundin; Kristina von Boguslawski; Caj Haglund
p27 expression correlates with short-term, but not with long-term prognosis in breast cancer.
Breast cancer research and treatment 2001;67(1):15-22.
2001: Johanna Louhimo; Stig Nordling; Henrik Alfthan; Kristina von Boguslawski; Ulf-Hakan Stenman; Caj Haglund
Specific staining of human chorionic gonadotropin beta in benign and malignant gastrointestinal tissues with monoclonal antibodies.
Histopathology 2001;38(5):418-24.
2001: Kaisa Salmenkivi; Johanna Arola; Raimo Voutilainen; V Ilvesmäki; Caj Haglund; AI Kahri; Päivi Heikkilä; Jianqi Liu
Inhibin/activin betaB-subunit expression in pheochromocytomas favors benign diagnosis.
The Journal of clinical endocrinology and metabolism 2001;86(5):2231-5.
2001: Johan Hedström; Caj Haglund; Jari Leinonen; Stig Nordling; Ulf-Hakan Stenman
Trypsinogen-1, -2 and tumour-associated trypsin-inhibitor in bile and biliary tract tissues from patients with biliary tract diseases and pancreatic carcinomas.
Scandinavian journal of clinical and laboratory investigation 2001;61(2):111-8.
2001: Samuli Hemmer; Veli-Matti Wasenius; Caj Haglund; Ying Zhu; Sakari Knuutila; Kaarle Franssila; Heikki Joensuu
Deletion of 11q23 and cyclin D1 overexpression are frequent aberrations in parathyroid adenomas.
The American journal of pathology 2001;158(4):1355-62.
2001: Ari Ristimäki; O Nieminen; Kirsi Saukkonen; Kristina Hotakainen; Stig Nordling; Caj Haglund
Expression of cyclooxygenase-2 in human transitional cell carcinoma of the urinary bladder.
The American journal of pathology 2001;158(3):849-53.
2001: Mikael Lundin; Stig Nordling; Johan Lundin; Henrik Alfthan; Ulf-Hakan Stenman; Caj Haglund
Tissue expression of human chorionic gonadotropin beta predicts outcome in colorectal cancer: a comparison with serum expression.
International journal of cancer. Journal international du cancer 2001;95(1):18-22.
2001: Jan-Patrik Wiksten; Johan Lundin; Stig Nordling; Mikael Lundin; Arto Kokkola; Kristina von Boguslawski; Caj Haglund
Epithelial and stromal syndecan-1 expression as predictor of outcome in patients with gastric cancer.
International journal of cancer. Journal international du cancer 2001;95(1):1-6.
2001: Marja Leivonen; Stig Nordling; Johan Lundin; Kristina von Boguslawski; Caj Haglund
STn and prognosis in breast cancer.
Oncology 2001;61(4):299-305.
2000: Jukka Sirén; Caj Haglund; Reijo Haapiainen
An institutional experience with 40 first lateral transperitoneal laparoscopic adrenalectomies.
Surgical laparoscopy, endoscopy & percutaneous techniques 2000;10(6):382-6.
2000: Mikael Lundin; Stig Nordling; M Carpelan-Holmstrom; Johanna Louhimo; Henrik Alfthan; Ulf-Hakan Stenman; Caj Haglund
A comparison of serum and tissue hCG beta as prognostic markers in colorectal cancer.
Anticancer research 2000;20(6D):4949-51.
2000: Jan-Patrik Wiksten; Johan Lundin; Stig Nordling; Arto Kokkola; Caj Haglund
A prognostic value of syndecan-1 in gastric cancer.
Anticancer research 2000;20(6D):4905-7.
2000: Petri E Voutilainen; Caj Haglund
Ultrasonically activated shears in thyroidectomies: a randomized trial.
Annals of surgery 2000;231(3):322-8.
2000: Petri E Voutilainen; MT Multanen; Reijo Haapiainen; Caj Haglund; Timo Sane; Anna Sivula
Long term prognosis of medullary thyroid carcinoma in 39 patients.
Annales chirurgiae et gynaecologiae 2000;89(4):292-7.
1999: Johan Hedström; Reidar Grenman; H Ramsay; Patrik Finne; Johan Lundin; Caj Haglund; Henrik Alfthan; Ulf-Hakan Stenman
Concentration of free hCGbeta subunit in serum as a prognostic marker for squamous-cell carcinoma of the oral cavity and oropharynx.
International journal of cancer. Journal international du cancer 1999;84(5):525-8.
1999: Johan Hedström; Caj Haglund; Esko Kemppainen; M Leinimaa; Jari Leinonen; Ulf-Hakan Stenman
Time-resolved immunofluorometric assay of trypsin-1 complexed with alpha(1)-antitrypsin in serum: increased immunoreactivity in patients with biliary tract cancer.
Clinical chemistry 1999;45(10):1768-73.
1999: Mikael Lundin; Stig Nordling; PJ Roberts; Johan Lundin; Monika Carpelan-Holmström; Kristina von Boguslawsky; Caj Haglund
Sialyl Tn is a frequently expressed antigen in colorectal cancer: No correlation with patient prognosis.
Oncology 1999;57(1):70-6.
1999: M Victorzon; Mikael Lundin; Caj Haglund; PJ Roberts; Ilmo Kellokumpu
Short and long term outcome after laparoscopic cholecystectomy.
Annales chirurgiae et gynaecologiae 1999;88(4):259-63.
1999: Jukka Sirén; Caj Haglund; K Huikuri; Anna Sivula; Reijo Haapiainen
Laparoscopic adrenalectomy for primary aldosteronism: clinical experience in 12 patients.
Surgical laparoscopy & endoscopy 1999;9(1):9-13.
1998: Tiina Jahkola; Terttu Toivonen; Ismo Virtanen; Karl von Smitten; Stig Nordling; Kristina von Boguslawski; Caj Haglund; Heli Nevanlinna; Carl Blomqvist
Tenascin-C expression in invasion border of early breast cancer: a predictor of local and distant recurrence.
British journal of cancer 1998;78(11):1507-13.
1998: Petri E Voutilainen; Reijo Haapiainen; Caj Haglund
Ultrasonically activated shears in thyroid surgery.
American journal of surgery 1998;175(6):491-3.
1998: Marja Leivonen; Stig Nordling; Caj Haglund
The course of Helicobacter pylori infection after partial gastrectomy for peptic ulcer disease.
Hepato-gastroenterology 1998;45(20):587-91.
1997: Marja Leivonen; Stig Nordling; Caj Haglund
Does Helicobacter pylori in the gastric stump increase the cancer risk after certain reconstruction types?
Anticancer research 1997;17(5B):3893-6.
1997: M Victorzon; PJ Roberts; Caj Haglund; Kristina von Boguslawsky; Stig Nordling
Ki-67, ploidy and S-phase fraction as prognostic factors in gastric cancer.
Anticancer research 1997;17(4B):2923-6.
1997: Marja Leivonen; Caj Haglund; S F Nordling
Helicobacter pylori infection after partial gastrectomy for peptic ulcer and its role in relapsing disease.
European journal of gastroenterology & hepatology 1997;9(4):371-4.
1997: Caj Haglund; S Ylätupa; P Mertaniemi; P Partanen
Cellular fibronectin concentration in the plasma of patients with malignant and benign diseases: a comparison with CA 19-9 and CEA.
British journal of cancer 1997;76(6):777-83.
1997: Mikael Railo; Johan Lundin; Caj Haglund; Karl von Smitten; Kristina von Boguslawsky; Stig Nordling
Ki-67, p53, Er-receptors, ploidy and S-phase as prognostic factors in T1 node negative breast cancer.
Acta oncologica (Stockholm, Sweden) 1997;36(4):369-74.
1996: M Carpelan-Holmström; Caj Haglund; Johan Lundin; Henrik Alfthan; Ulf-Hakan Stenman; P J Roberts
Independent prognostic value of preoperative serum markers CA 242, specific tissue polypeptide antigen and human chorionic gonadotrophin beta, but not of carcinoembryonic antigen or tissue polypeptide antigen in colorectal cancer.
British journal of cancer 1996;74(6):925-9.
1996: M Victorzon; Johan Lundin; Caj Haglund; Stig Nordling; P J Roberts
A risk score for predicting outcome in patients with gastric cancer, based on stage, sialyl-Tn immunoreactivity and ploidy--a multivariate analysis.
International journal of cancer. Journal international du cancer 1996;67(2):190-3.
1996: M A Carpelan-Holmström; Caj Haglund; P J Roberts
Differences in serum tumor markers between colon and rectal cancer. Comparison of CA 242 and carcinoembryonic antigen.
Diseases of the colon and rectum 1996;39(7):799-805.
1996: M Carpelan-Holmström; Caj Haglund; Johan Lundin; Heikki Järvinen; P Roberts
Pre-operative serum levels of CA 242 and CEA predict outcome in colorectal cancer.
European journal of cancer (Oxford, England : 1990) 1996;32A(7):1156-61.
1996: Johan Hedström; Caj Haglund; Reijo Haapiainen; Ulf-Hakan Stenman
Serum trypsinogen-2 and trypsin-2-alpha(1)-antitrypsin complex in malignant and benign digestive-tract diseases. Preferential elevation in patients with cholangiocarcinomas.
International journal of cancer. Journal international du cancer 1996;66(3):326-31.
1996: M Victorzon; P J Roberts; Caj Haglund; Kristina von Boguslawsky; Stig Nordling
Ki-67 immunoreactivity, ploidy and S-phase fraction as prognostic factors in patients with gastric carcinoma.
Oncology 1996;53(3):182-91.
1996: M A Carpelan-Holmström; Caj Haglund; H J Järvinen; P J Roberts
Serum CA 242 and CEA detect different patients with recurrent colorectal cancer.
Anticancer research 1996;16(2):981-6.
1996: Johan Lundin; Stig Nordling; Kristina von Boguslawsky; P J Roberts; Caj Haglund
Prognostic value of immunohistochemical expression of p53 in patients with pancreatic cancer.
Oncology 1996;53(2):104-11.
1996: M Victorzon; Stig Nordling; Caj Haglund; Johan Lundin; P J Roberts
Expression of p53 protein as a prognostic factor in patients with gastric cancer.
European journal of cancer (Oxford, England : 1990) 1996;32A(2):215-20.
1996: M Victorzon; Stig Nordling; O Nilsson; P J Roberts; Caj Haglund
Sialyl Tn antigen is an independent predictor of outcome in patients with gastric cancer.
International journal of cancer. Journal international du cancer 1996;65(3):295-300.
1995: Johan Lundin; Stig Nordling; Kristina von Boguslawsky; P J Roberts; Caj Haglund
Prognostic value of Ki-67 expression, ploidy and S-phase fraction in patients with pancreatic cancer.
Anticancer research 1995;15(6B):2659-68.
1995: Johan Lundin; P J Roberts; P Kuusela; Caj Haglund
Prognostic significance of serum CA 242 in pancreatic cancer. A comparison with CA 19-9.
Anticancer research 1995;15(5B):2181-6.
1995: M Victorzon; Caj Haglund; Johan Lundin; P J Roberts
A prognostic value of CA 19-9 but not of CEA in patients with gastric cancer.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 1995;21(4):379-84.
1995: S Ylätupa; P Mertaniemi; Caj Haglund; P Partanen
Enzyme immunoassay for quantification of tenascin in biologic samples.
Clinical biochemistry 1995;28(3):263-8.
1995: M Carpelan-Holmström; Caj Haglund; P Kuusela; Heikki Järvinen; P J Roberts
Preoperative serum levels of CEA and CA 242 in colorectal cancer.
British journal of cancer 1995;71(4):868-72.
1995: S Ylätupa; Caj Haglund; P Mertaniemi; E Vahtera; P Partanen
Cellular fibronectin in serum and plasma: a potential new tumour marker?
British journal of cancer 1995;71(3):578-82.
1995: B Scheinin; Ilmo Kellokumpu; Leena Lindgren; Caj Haglund; Per H Rosenberg
Effect of intraperitoneal bupivacaine on pain after laparoscopic cholecystectomy.
Acta anaesthesiologica Scandinavica 1995;39(2):195-8.
1995: S Ylätupa; P Mertaniemi; Caj Haglund; P Partanen
An improved method for quantification of extra domain A-containing cellular fibronectin (EDAcFN) in different body fluids.
Clinica chimica acta; international journal of clinical chemistry 1995;234(1-2):79-90.
1994: Caj Haglund; Johan Lundin; P Kuusela; P J Roberts
CA 242, a new tumour marker for pancreatic cancer: a comparison with CA 19-9, CA 50 and CEA.
British journal of cancer 1994;70(3):487-92.
1994: Johan Lundin; P J Roberts; P Kuusela; Caj Haglund
The prognostic value of preoperative serum levels of CA 19-9 and CEA in patients with pancreatic cancer.
British journal of cancer 1994;69(3):515-9.
1994: Leena Halme; Caj Haglund; Stig Nordling; J Ahonen
Large mesenteric mass caused by a mesenteric desmoid tumour.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 1994;20(1):69-72.
1993: S Ylätupa; P Partanen; Caj Haglund; Ismo Virtanen
Competitive enzyme immunoassay for quantification of the cellular form of fibronectin (EDAcFN) in blood samples.
Journal of immunological methods 1993;163(1):41-7.
1992: Henrik Alfthan; Caj Haglund; J Dabek; Ulf-Hakan Stenman
Concentrations of human choriogonadotropin, its beta-subunit, and the core fragment of the beta-subunit in serum and urine of men and nonpregnant women.
Clinical chemistry 1992;38(10):1981-7.
1992: Henrik Alfthan; Caj Haglund; P Roberts; Ulf-Hakan Stenman
Elevation of free beta subunit of human choriogonadotropin and core beta fragment of human choriogonadotropin in the serum and urine of patients with malignant pancreatic and biliary disease.
Cancer research 1992;52(17):4628-33.
1992: A L Söderholm; Christian Lindqvist; Caj Haglund
Tumour markers and radiological examinations in the follow-up of patients with oral cancer.
Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery 1992;20(5):211-5.
1992: Caj Haglund; P J Roberts; Hannu Jalanko; P Kuusela
Tumour markers CA 19-9 and CA 50 in digestive tract malignancies.
Scandinavian journal of gastroenterology 1992;27(3):169-74.
1991: Caj Haglund; P Kuusela; P Roberts; Hannu Jalanko
Tumour marker CA 125 in patients with digestive tract malignancies.
Scandinavian journal of clinical and laboratory investigation 1991;51(3):265-270.
1991: P Kuusela; Caj Haglund; P J Roberts
Comparison of a new tumour marker CA 242 with CA 19-9, CA 50 and carcinoembryonic antigen (CEA) in digestive tract diseases.
British journal of cancer 1991;63(4):636-40.
1991: Caj Haglund; J Lindgren; P J Roberts; Stig Nordling
Difference in tissue expression of tumour markers CA 19-9 and CA 50 in hepatocellular carcinoma and cholangiocarcinoma.
British journal of cancer 1991;63(3):386-9.
1989: Caj Haglund; J Lindgren; P J Roberts; P Kuusela; Stig Nordling
Tissue expression of the tumour associated antigen CA242 in benign and malignant pancreatic lesions. A comparison with CA 50 and CA 19-9.
British journal of cancer 1989;60(6):845-51.
1989: Caj Haglund; P J Roberts; Stig Nordling
Expression of laminin in benign and malignant sclerosing lesions of extrahepatic bile ducts.
Journal of clinical pathology 1989;42(9):927-30.
1989: Caj Haglund; P Kuusela; P J Roberts
Tumour markers in pancreatic cancer.
Annales chirurgiae et gynaecologiae 1989;78(1):41-53.
1989: P J Roberts; Caj Haglund; M Onali; P Kuusela
Tumour markers in gastric cancer.
Annales chirurgiae et gynaecologiae 1989;78(1):38-40.
1987: H Halila; M L Huhtala; Caj Haglund; Stig Nordling; Ulf-Hakan Stenman
Tumour-associated trypsin inhibitor (TATI) in human ovarian cyst fluid. Comparison with CA 125 and CEA.
British journal of cancer 1987;56(2):153-6.
1986: Caj Haglund; J Lindgren; P J Roberts; Stig Nordling
Tissue expression of the tumor marker CA 50 in benign and malignant pancreatic lesions. A comparison with CA 19-9.
International journal of cancer. Journal international du cancer 1986;38(6):841-6.
1986: Caj Haglund; M L Huhtala; H Halila; Stig Nordling; P J Roberts; T M Scheinin; Ulf-Hakan Stenman
Tumour-associated trypsin inhibitor, TATI, in patients with pancreatic cancer, pancreatitis and benign biliary diseases.
British journal of cancer 1986;54(2):297-303.
1986: Caj Haglund; J Lindgren; P J Roberts; Stig Nordling
Gastrointestinal cancer-associated antigen CA 19-9 in histological specimens of pancreatic tumours and pancreatitis.
British journal of cancer 1986;53(2):189-95.
1986: Caj Haglund; P J Roberts; P Kuusela; T M Scheinin; O Mäkelä; H Jalanko
Evaluation of CA 19-9 as a serum tumour marker in pancreatic cancer.
British journal of cancer 1986;53(2):197-202.